ZA951778B - In-vitro anglogenesis assay - Google Patents

In-vitro anglogenesis assay

Info

Publication number
ZA951778B
ZA951778B ZA951778A ZA951778A ZA951778B ZA 951778 B ZA951778 B ZA 951778B ZA 951778 A ZA951778 A ZA 951778A ZA 951778 A ZA951778 A ZA 951778A ZA 951778 B ZA951778 B ZA 951778B
Authority
ZA
South Africa
Prior art keywords
anglogenesis
vitro
assay
vitro anglogenesis
anglogenesis assay
Prior art date
Application number
ZA951778A
Other languages
English (en)
Inventor
Christopher Richard Parish
Kathryn Joanna Isabel Brown
Susan Faye Maynes
Anna Bezos
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Publication of ZA951778B publication Critical patent/ZA951778B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA951778A 1994-03-04 1995-03-03 In-vitro anglogenesis assay ZA951778B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM4252A AUPM425294A0 (en) 1994-03-04 1994-03-04 In-vitro angiogenesis assay

Publications (1)

Publication Number Publication Date
ZA951778B true ZA951778B (en) 1996-01-25

Family

ID=3778868

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951778A ZA951778B (en) 1994-03-04 1995-03-03 In-vitro anglogenesis assay

Country Status (9)

Country Link
US (1) US5976782A (fr)
EP (1) EP0804727A4 (fr)
JP (1) JPH09509829A (fr)
AU (1) AUPM425294A0 (fr)
CA (1) CA2184705A1 (fr)
IL (1) IL112844A (fr)
TW (1) TW394844B (fr)
WO (1) WO1995023968A1 (fr)
ZA (1) ZA951778B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2331763B (en) * 1997-10-01 2000-03-22 Biocure Ltd A Multicellular in vitro assay of angiogenesis
US6225118B1 (en) 1997-10-01 2001-05-01 Biocure Limited Multicellular in vitro assay of angiogenesis
FR2798674B1 (fr) * 1999-09-21 2004-01-30 Mahmood Salman Al Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques
US6329348B1 (en) 1999-11-08 2001-12-11 Cornell Research Foundation, Inc. Method of inducing angiogenesis
US6893812B2 (en) * 2000-05-30 2005-05-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Three-dimensional ex vivo angiogenesis system
EP1315797A2 (fr) * 2000-09-06 2003-06-04 Universit Laval Modele d'angiogenese humaine in vitro
US6436629B1 (en) 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
US20020146679A1 (en) * 2001-01-29 2002-10-10 Karathanasis Sotirios K. Method for creating endothelial cell dysfunction in cell culture
ES2185493B1 (es) * 2001-07-03 2004-06-16 Madrid Genetics, S.L. Metodo para evaluar in vitro en condiciones fisiologicas o patologicas relevantes la actividad biologica de compuestos a gran escala.
IL160422A0 (en) * 2001-08-29 2004-07-25 Genentech Inc Bv8 nucleic acids and polypeptides with mitogenic activity
JP4486815B2 (ja) * 2001-09-27 2010-06-23 バイオノミックス リミテッド ヒト血管形成遺伝子に対するｄｎａ配列
WO2003046139A2 (fr) * 2001-11-26 2003-06-05 Exelixis, Inc. Genes crb en tant que modificateurs de la morphogenese ramifiee et ses methodes d'utilisation
WO2003086373A1 (fr) * 2002-04-12 2003-10-23 Celgene Corporation Techniques d'identification de modulateurs d'angiogenese, composes decouverts par ces techniques et techniques de traitement utilisant ces composes
WO2004002413A2 (fr) 2002-06-26 2004-01-08 Children's Hospital Medical Center Bioanalyse de l'angiogenèse in vivo
FR2845691B1 (fr) * 2002-10-10 2004-12-10 Centre Nat Rech Scient Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese
SE526959C2 (sv) * 2003-10-02 2005-11-29 Tikomed Ab Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
WO2009078015A2 (fr) * 2007-12-18 2009-06-25 Procognia (Israel) Ltd Procédé et dosage pour la détection de motifs de glycosylation reliés à l'état cellulaire de cellules souches
CA2908562A1 (fr) * 2013-04-02 2014-10-09 Peter S. Mcfetridge Compositions et procedes permettant d'induire et de moduler l'angiogenese et procedes et dosages permettant d'identifier des modulateurs de l'angiogenese
US11884647B2 (en) 2019-10-18 2024-01-30 The Regents Of The University Of California Compounds and methods for targeting pathogenic blood vessels
WO2021076915A1 (fr) * 2019-10-18 2021-04-22 The Regents Of The University Of California Modèle d'angiogenèse tumorale ex vivo
CN111518746A (zh) * 2020-05-18 2020-08-11 南通大学 一种角膜微口袋手术实验中微丸的制备方法及应用

Also Published As

Publication number Publication date
JPH09509829A (ja) 1997-10-07
AUPM425294A0 (en) 1994-03-31
IL112844A0 (en) 1995-06-29
EP0804727A4 (fr) 1998-08-05
CA2184705A1 (fr) 1995-09-08
EP0804727A1 (fr) 1997-11-05
WO1995023968A1 (fr) 1995-09-08
IL112844A (en) 1998-12-06
TW394844B (en) 2000-06-21
US5976782A (en) 1999-11-02

Similar Documents

Publication Publication Date Title
ZA951778B (en) In-vitro anglogenesis assay
GB9719044D0 (en) Assay
GB9715034D0 (en) Assay
GB9614351D0 (en) Assay
GB9610195D0 (en) Assay
AU4713596A (en) Assay apparatus
GB9410044D0 (en) Assay
GB9606887D0 (en) Assay
GB9721240D0 (en) Assay
GB9619168D0 (en) Assay
GB9408607D0 (en) Assay
ZA944336B (en) Assay
GB9308544D0 (en) Assay
GB9621256D0 (en) Assay
GB9420218D0 (en) Combined assay
GB9614477D0 (en) Assay
GB9410174D0 (en) Assay
GB9410346D0 (en) Improved assay
GB9719428D0 (en) Assay
GB9420682D0 (en) Assay methods
GB9416724D0 (en) Assay system
GB9401006D0 (en) Assay system
GB9400353D0 (en) Enzyme assay
GB9507110D0 (en) Assay
GB9506045D0 (en) Assay